Toulouse, capital of France’s southern Occitanie region, is bisected by the Garonne River and sits near the Spanish border. It’s known as La Ville Rose (‘The Pink City’) due to the terra-cotta bricks used in many of its buildings. Its 17th-century Canal du Midi links the Garonne to the Mediterranean Sea, and can be traveled by boat, bike or on foot. ― Google

During the past decade, UHToulouse conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UHToulouse" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "French Association for Research on Multiple Sclerosis" with 1 trials as a collaborator, "MSD France" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator and "Neovii Biotech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UHToulouse" are "Anesthesia" (2 trials), "Anterior Cruciate Ligament Reconstruction" (1 trials), "Asthma Chronic" (1 trials), "Cardiomyopathies" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "UHToulouse" in a lesser frequency.

Most popular intervention types in "UHToulouse" are "Other" (13 trials), "Drug" (5 trials), "Procedure" (3 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "telemedicine" (2 trials), "ATG Fresenius" (1 trials), "Anterior Cruciate Ligament reconstruction (ACLR)" (1 trials), "Arm Activity Measure (ArmA) in french" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "UHToulouse" are 24 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UHToulouse". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in UHToulouse, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UHToulouse, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".